MA30636B1 - Promedicament d'un compose cinnamide - Google Patents
Promedicament d'un compose cinnamideInfo
- Publication number
- MA30636B1 MA30636B1 MA31628A MA31628A MA30636B1 MA 30636 B1 MA30636 B1 MA 30636B1 MA 31628 A MA31628 A MA 31628A MA 31628 A MA31628 A MA 31628A MA 30636 B1 MA30636 B1 MA 30636B1
- Authority
- MA
- Morocco
- Prior art keywords
- promedicing
- cinnamide compound
- formula
- group
- cinnamide
- Prior art date
Links
- -1 CINNAMIDE COMPOUND Chemical class 0.000 title abstract 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 125000001153 fluoro group Chemical group F* 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 125000001476 phosphono group Chemical group [H]OP(*)(=O)O[H] 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Saccharide Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Seasonings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Cultivation Of Plants (AREA)
Abstract
La présente invention décrit un précurseur de médicament optimal d'un composé cinnamide représenté par la Formule (1) ci-dessous. Dans la formule, Ra et Rb représentent, respectivement, un groupe alkyle en Cl-6 ou similaire; Xa représente un groupe méthoxy ou un atome de fluor; Y représente un groupe phosphono ou similaire; et A représente un dérivé de lactame cyclique.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82076106P | 2006-07-28 | 2006-07-28 | |
JP2006206007 | 2006-07-28 | ||
US86925906P | 2006-12-08 | 2006-12-08 | |
JP2006331274 | 2006-12-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA30636B1 true MA30636B1 (fr) | 2009-08-03 |
Family
ID=38981524
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA31628A MA30636B1 (fr) | 2006-07-28 | 2009-02-11 | Promedicament d'un compose cinnamide |
Country Status (25)
Country | Link |
---|---|
US (1) | US7737141B2 (fr) |
EP (1) | EP2048143A4 (fr) |
JP (1) | JPWO2008013213A1 (fr) |
KR (1) | KR20090033910A (fr) |
AR (1) | AR062095A1 (fr) |
AU (1) | AU2007277729A1 (fr) |
CA (1) | CA2658037A1 (fr) |
CO (1) | CO6150153A2 (fr) |
CR (1) | CR10499A (fr) |
EA (1) | EA200970172A1 (fr) |
EC (1) | ECSP099091A (fr) |
GE (1) | GEP20115176B (fr) |
HN (1) | HN2009000157A (fr) |
IL (1) | IL196351A0 (fr) |
MA (1) | MA30636B1 (fr) |
MX (1) | MX2008015504A (fr) |
MY (1) | MY144971A (fr) |
NO (1) | NO20090541L (fr) |
NZ (1) | NZ574102A (fr) |
PE (1) | PE20080281A1 (fr) |
SA (1) | SA07280403B1 (fr) |
SV (1) | SV2009003157A (fr) |
TN (1) | TN2009000024A1 (fr) |
TW (1) | TW200821319A (fr) |
WO (1) | WO2008013213A1 (fr) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2261218B1 (fr) | 2004-05-26 | 2013-04-03 | Eisai R&D Management Co., Ltd. | Imidazolverbindung zur Verwendung als Intermediat in der Herstellung von Cinnamid-Verbindungen |
ATE458729T1 (de) * | 2004-10-26 | 2010-03-15 | Eisai R&D Man Co Ltd | Amorphe form einer zimtsäureamidverbindung |
WO2007058304A1 (fr) * | 2005-11-18 | 2007-05-24 | Eisai R & D Management Co., Ltd. | Sels de composé cynamide ou solvates de ces derniers |
WO2007058305A1 (fr) * | 2005-11-18 | 2007-05-24 | Eisai R & D Management Co., Ltd. | Procede de production d’un derive cinnamamide |
BRPI0618814A2 (pt) * | 2005-11-24 | 2014-04-29 | Eisai R&D Man Co Ltd | Composto ou um sal farmacologicamente aceitável do mesmo, e, agente farmacêutico |
TWI370130B (en) * | 2005-11-24 | 2012-08-11 | Eisai R&D Man Co Ltd | Two cyclic cinnamide compound |
TWI378091B (en) * | 2006-03-09 | 2012-12-01 | Eisai R&D Man Co Ltd | Multi-cyclic cinnamide derivatives |
SA07280403B1 (ar) | 2006-07-28 | 2010-12-01 | إيساي أر أند دي منجمنت كو. ليمتد | ملح رباعي لمركب سيناميد |
CL2008000582A1 (es) * | 2007-02-28 | 2008-06-27 | Eisai R&D Man Co Ltd | Compuestos ciclicos derivados de oximorfolina condensados; farmacos que comprenden a dichos compuestos; y su uso para tratar enfermedad de alzheimer, demencia senil, sindrome de down o amiloidosis. |
KR20100016580A (ko) * | 2007-05-16 | 2010-02-12 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 신나미드 유도체의 원폿 제조 방법 |
US7935815B2 (en) * | 2007-08-31 | 2011-05-03 | Eisai R&D Management Co., Ltd. | Imidazoyl pyridine compounds and salts thereof |
NZ583515A (en) | 2007-08-31 | 2011-05-27 | Eisai R&D Man Co Ltd | Imidazole-pyridine derivative featuring a 1,2,4-triazole ring fused to a 5-7 membered ring, for treating a disease caused by amyloid-beta such as Alzheimer's, dementia, Down's syndrome, and amyloidosis |
KR20100135711A (ko) | 2007-12-20 | 2010-12-27 | 엔비보 파마슈티칼즈, 인코퍼레이티드 | 사중치환된 벤젠 |
WO2009080533A1 (fr) | 2007-12-21 | 2009-07-02 | F. Hoffmann-La Roche Ag | Dérivés hétéroaryles en tant qu'antagonistes du récepteur à orexine |
WO2009087127A1 (fr) | 2008-01-11 | 2009-07-16 | F. Hoffmann-La Roche Ag | Modulateurs pour l'amyloïde-bêta |
CA2712095A1 (fr) * | 2008-01-28 | 2009-08-06 | Eisai R&D Management Co., Ltd. | Composes cristallins de cinnamide ou sels de ceux-ci |
WO2009103652A1 (fr) | 2008-02-22 | 2009-08-27 | F. Hoffmann-La Roche Ag | Modulateurs de la bêta-amyloïde |
CA2736924C (fr) | 2008-10-09 | 2016-06-28 | F. Hoffmann-La Roche Ag | Modulateurs pour l'amyloide beta |
BRPI0921348A2 (pt) | 2008-11-10 | 2019-09-24 | Hoffmann La Roche | moduladores heterocíclicos da gama secretase |
US8486967B2 (en) | 2010-02-17 | 2013-07-16 | Hoffmann-La Roche Inc. | Heteroaryl substituted piperidines |
BR112013000050B1 (pt) * | 2010-07-02 | 2021-10-19 | Bio-Pharm Solutions Co., Ltd | Compostos de carbamato de fenila e composição farmacêutica |
US9018253B2 (en) | 2010-07-02 | 2015-04-28 | Bio-Pharm Solutions Co., Ltd. | Phenylcarbamate compound and muscle relaxant containing the same |
KR101551041B1 (ko) | 2011-01-13 | 2015-09-07 | (주)바이오팜솔루션즈 | 페닐 카바메이트 유도체의 제조방법 |
JP6038130B2 (ja) | 2011-06-15 | 2016-12-07 | ビーエーエスエフ ソシエタス・ヨーロピアBasf Se | スルホネート基を有する分岐状ポリエステル |
US8901066B2 (en) | 2011-06-15 | 2014-12-02 | Basf Se | Branched polyesters with sulfonate groups |
RU2014124029A (ru) * | 2011-12-27 | 2016-02-20 | Байо-Фарм Солюшнс Ко., Лтд. | Фенилкарбаматные соединения для применения в облегчении или лечении боли и невропатической боли |
CN109939092B (zh) | 2013-03-12 | 2022-03-22 | 比皮艾思药物研发有限公司 | 用于预防或治疗小儿癫痫和癫痫相关综合征的苯基氨基甲酸酯化合物 |
CN105189451A (zh) * | 2013-03-12 | 2015-12-23 | 比皮艾思药物研发有限公司 | 氨基甲酸苯酯化合物和包含该化合物的用于预防或治疗神经性毒气引起的疾病的组合物 |
WO2018107060A1 (fr) * | 2016-12-09 | 2018-06-14 | Denali Therapeutics Inc. | Composés, compositions et méthodes |
CN110143935B (zh) * | 2019-06-03 | 2022-09-30 | 华侨大学 | 一种2,5-二取代呋喃衍生物的制备方法 |
Family Cites Families (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0219756B1 (fr) * | 1985-10-09 | 1994-01-05 | Shell Internationale Researchmaatschappij B.V. | Amides de l'acide acrylique |
DE3541716A1 (de) | 1985-11-26 | 1987-05-27 | Celamerck Gmbh & Co Kg | Neue acrylsaeureamide |
JPH03206042A (ja) | 1990-01-06 | 1991-09-09 | Takeda Chem Ind Ltd | 降圧剤 |
DE69126251T2 (de) | 1990-02-08 | 1997-09-25 | Eisai Co Ltd | Benzensulfonamidderivat |
JPH05194517A (ja) | 1992-01-16 | 1993-08-03 | Tanabe Seiyaku Co Ltd | 6−メルカプトプリン誘導体及びその製法 |
AU680870B2 (en) * | 1993-04-28 | 1997-08-14 | Astellas Pharma Inc. | New heterocyclic compounds |
EP0784612A1 (fr) | 1994-10-04 | 1997-07-23 | Fujisawa Pharmaceutical Co., Ltd. | Derives d'uree et leur utilisation comme inhibiteurs de l'acat |
JPH08283219A (ja) | 1995-04-07 | 1996-10-29 | Eisai Co Ltd | アラルキルアミノアルキルアミド誘導体 |
CA2253948C (fr) * | 1996-05-10 | 2005-07-26 | Icos Corporation | Derives de carboline |
KR20000067964A (ko) | 1996-07-22 | 2000-11-25 | 죤 에이치. 뷰센 | 티올 술폰아미드 메탈로프로테아제 저해제 |
JP2001508767A (ja) | 1996-12-02 | 2001-07-03 | 藤沢薬品工業株式会社 | 5―ht拮抗作用を有するインドール―ウレア誘導体 |
KR20010005792A (ko) | 1997-03-31 | 2001-01-15 | 다케다 야쿠힌 고교 가부시키가이샤 | 아졸 화합물, 이의 제조 방법 및 용도 |
JP3108997B2 (ja) | 1997-03-31 | 2000-11-13 | 武田薬品工業株式会社 | アゾール化合物、その製造法および用途 |
WO1999033846A2 (fr) | 1997-12-31 | 1999-07-08 | The University Of Kansas | Remedes contenant des precurseurs hydrosolubles d'amines secondaires et tertiaires, et leurs procedes d'obtention |
GB9816984D0 (en) | 1998-08-05 | 1998-09-30 | Smithkline Beecham Plc | Novel compounds |
US6235728B1 (en) * | 1999-02-19 | 2001-05-22 | Bristol-Myers Squibb Company | Water-soluble prodrugs of azole compounds |
EP1159263A1 (fr) | 1999-02-26 | 2001-12-05 | Merck & Co., Inc. | Nouveaux composes de sulfonamide et utilisations correspondantes |
AU2899400A (en) | 1999-03-04 | 2000-09-21 | Nortran Pharmaceuticals Inc. | Aminocycloalkyl cinnamide compounds for arrhythmia and as analgesics and anesthetics |
AU2001241128A1 (en) | 2000-03-14 | 2001-09-24 | Fujisawa Pharmaceutical Co. Ltd. | Novel amide compounds |
US20010051642A1 (en) * | 2000-04-17 | 2001-12-13 | Kyunghye Ahn | Method for treating Alzheimer's disease |
CA2405170A1 (fr) | 2000-04-24 | 2001-11-01 | Merck Frosst Canada & Co. | Methode de traitement se basant sur l'utilisation de derives de phenyle et de biaryle comme inhibiteurs de prostaglandine e |
SK8402003A3 (en) * | 2000-12-04 | 2004-04-06 | Hoffmann La Roche | Phenylethenyl or phenylethinyl derivatives as glutamate receptor or antagonists |
GB0108770D0 (en) | 2001-04-06 | 2001-05-30 | Eisai London Res Lab Ltd | Inhibitors |
AU2002364549B2 (en) | 2001-12-10 | 2007-11-22 | Amgen, Inc | Vanilloid receptor ligands and their use in treatments |
HUP0500173A3 (en) * | 2001-12-20 | 2009-03-30 | Bristol Myers Squibb Co | Alpha-sulphonamido-acetamide derivatives as beta-amyloid inhibitors and pharmaceutical compositions containing them |
JP2003206280A (ja) | 2001-12-28 | 2003-07-22 | Takeda Chem Ind Ltd | ビアリール化合物およびその用途 |
DE10211101A1 (de) | 2002-03-14 | 2003-09-25 | Basf Ag | Katalysatoren und Verfahren zur Herstellung von Aminen |
GB0207436D0 (en) | 2002-03-28 | 2002-05-08 | Glaxo Group Ltd | Novel compounds |
WO2003099284A1 (fr) * | 2002-05-22 | 2003-12-04 | Amgen Inc. | Amino-pyridine, derives de pyridine et de pyridazine utilises comme ligands de recepteur vanilloide permettant de traiter une douleur |
ES2473581T3 (es) | 2002-05-31 | 2014-07-07 | Proteotech Inc. | Compuestos, composiciones y métodos para el tratamiento de amiloidosis y sinucleinopat�as tales como la enfermedad de Alzheimer, la diabetes de tipo 2 y la enfermedad de Parkinson |
PL373329A1 (en) * | 2002-07-12 | 2005-08-22 | Sanofi-Aventis Deutschland Gmbh | Heterocyclically substituted benzoylureas, method for their production and their use as medicaments |
US6900354B2 (en) * | 2002-07-15 | 2005-05-31 | Hoffman-La Roche Inc. | 3-phenyl-propionamido, 3-phenyl-acrylamido and 3-phenyl-propynamido derivatives |
CA2514363A1 (fr) * | 2003-02-12 | 2004-08-26 | Transtech Pharma, Inc. | Utilisation de derives d'azoles substitues en tant qu'agents therapeutiques |
JP4847868B2 (ja) * | 2003-05-14 | 2011-12-28 | ニューロジェネティック ファーマシューティカルズ、 インコーポレイテッド | 化合物、及び、アミロイドベータの調節におけるその使用 |
WO2005020921A2 (fr) | 2003-08-29 | 2005-03-10 | Exelixis, Inc. | Modulateurs c-kit et leurs procedes d'utilisation |
OA13347A (en) | 2003-12-22 | 2007-04-13 | Pfizer | Triazole derivatives as vasopressin antagonists. |
AU2005214349B2 (en) * | 2004-02-12 | 2011-11-03 | Transtech Pharma, Inc. | Substituted azole derivatives, compositions, and methods of use |
EP2261218B1 (fr) * | 2004-05-26 | 2013-04-03 | Eisai R&D Management Co., Ltd. | Imidazolverbindung zur Verwendung als Intermediat in der Herstellung von Cinnamid-Verbindungen |
ATE458729T1 (de) | 2004-10-26 | 2010-03-15 | Eisai R&D Man Co Ltd | Amorphe form einer zimtsäureamidverbindung |
US20060241038A1 (en) | 2005-04-20 | 2006-10-26 | Eisai Co., Ltd. | Therapeutic agent for Abeta related disorders |
WO2007034282A2 (fr) | 2005-09-19 | 2007-03-29 | Pfizer Products Inc. | Composes de biphenylimidazole utilises comme antagonistes du recepteur du c3a |
WO2007058304A1 (fr) * | 2005-11-18 | 2007-05-24 | Eisai R & D Management Co., Ltd. | Sels de composé cynamide ou solvates de ces derniers |
WO2007058305A1 (fr) * | 2005-11-18 | 2007-05-24 | Eisai R & D Management Co., Ltd. | Procede de production d’un derive cinnamamide |
BRPI0618814A2 (pt) * | 2005-11-24 | 2014-04-29 | Eisai R&D Man Co Ltd | Composto ou um sal farmacologicamente aceitável do mesmo, e, agente farmacêutico |
TWI370130B (en) | 2005-11-24 | 2012-08-11 | Eisai R&D Man Co Ltd | Two cyclic cinnamide compound |
US20070117839A1 (en) * | 2005-11-24 | 2007-05-24 | Eisai R&D Management Co., Ltd. | Two cyclic cinnamide compound |
TWI378091B (en) * | 2006-03-09 | 2012-12-01 | Eisai R&D Man Co Ltd | Multi-cyclic cinnamide derivatives |
KR101464651B1 (ko) | 2006-03-09 | 2014-11-24 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 다환식 신나미드 유도체 |
SA07280403B1 (ar) | 2006-07-28 | 2010-12-01 | إيساي أر أند دي منجمنت كو. ليمتد | ملح رباعي لمركب سيناميد |
CA2677296A1 (fr) | 2007-02-08 | 2008-08-14 | Merck & Co., Inc. | Agents therapeutiques |
CA2686589A1 (fr) | 2007-05-07 | 2008-11-13 | Schering Corporation | Modulateurs de gamma secretase |
BRPI0811993A2 (pt) * | 2007-05-11 | 2014-11-18 | Hoffmann La Roche | " hetarilanilinas como moduladores para beta-amiloide ". |
EP2166854A4 (fr) | 2007-06-13 | 2012-05-16 | Merck Sharp & Dohme | Dérivés du triazole destinés au traitement de la maladie d'alzheimer et d'états associés |
WO2009020580A1 (fr) | 2007-08-06 | 2009-02-12 | Schering Corporation | Modulateurs de la gamma-sécrétase |
-
2007
- 2007-07-25 SA SA7280403A patent/SA07280403B1/ar unknown
- 2007-07-25 AR ARP070103296A patent/AR062095A1/es unknown
- 2007-07-25 US US11/878,556 patent/US7737141B2/en not_active Expired - Fee Related
- 2007-07-26 PE PE2007000966A patent/PE20080281A1/es not_active Application Discontinuation
- 2007-07-26 TW TW096127264A patent/TW200821319A/zh unknown
- 2007-07-26 NZ NZ574102A patent/NZ574102A/en not_active IP Right Cessation
- 2007-07-26 GE GEAP200711078A patent/GEP20115176B/en unknown
- 2007-07-26 CA CA002658037A patent/CA2658037A1/fr not_active Abandoned
- 2007-07-26 WO PCT/JP2007/064637 patent/WO2008013213A1/fr active Application Filing
- 2007-07-26 EA EA200970172A patent/EA200970172A1/ru unknown
- 2007-07-26 JP JP2008526796A patent/JPWO2008013213A1/ja not_active Abandoned
- 2007-07-26 AU AU2007277729A patent/AU2007277729A1/en not_active Abandoned
- 2007-07-26 EP EP07791337A patent/EP2048143A4/fr not_active Withdrawn
- 2007-07-26 KR KR1020097004007A patent/KR20090033910A/ko not_active Application Discontinuation
- 2007-07-26 MX MX2008015504A patent/MX2008015504A/es not_active Application Discontinuation
- 2007-07-26 MY MYPI20090056A patent/MY144971A/en unknown
-
2008
- 2008-12-11 CR CR10499A patent/CR10499A/es not_active Application Discontinuation
-
2009
- 2009-01-05 IL IL196351A patent/IL196351A0/en unknown
- 2009-01-06 CO CO09000699A patent/CO6150153A2/es unknown
- 2009-01-23 TN TN2009000024A patent/TN2009000024A1/fr unknown
- 2009-01-26 HN HN2009000157A patent/HN2009000157A/es unknown
- 2009-01-27 EC EC2009009091A patent/ECSP099091A/es unknown
- 2009-01-28 SV SV2009003157A patent/SV2009003157A/es unknown
- 2009-02-03 NO NO20090541A patent/NO20090541L/no not_active Application Discontinuation
- 2009-02-11 MA MA31628A patent/MA30636B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
GEP20115176B (en) | 2011-03-10 |
CO6150153A2 (es) | 2010-04-20 |
US20090048213A1 (en) | 2009-02-19 |
AU2007277729A1 (en) | 2008-01-31 |
KR20090033910A (ko) | 2009-04-06 |
EP2048143A4 (fr) | 2010-11-03 |
HN2009000157A (es) | 2011-01-24 |
US7737141B2 (en) | 2010-06-15 |
IL196351A0 (en) | 2009-09-22 |
MY144971A (en) | 2011-11-30 |
ECSP099091A (es) | 2009-02-27 |
PE20080281A1 (es) | 2008-05-05 |
WO2008013213A1 (fr) | 2008-01-31 |
AR062095A1 (es) | 2008-10-15 |
JPWO2008013213A1 (ja) | 2009-12-17 |
CA2658037A1 (fr) | 2008-01-31 |
TW200821319A (en) | 2008-05-16 |
NO20090541L (no) | 2009-02-03 |
SV2009003157A (es) | 2010-01-12 |
EP2048143A1 (fr) | 2009-04-15 |
CR10499A (es) | 2009-03-20 |
MX2008015504A (es) | 2008-12-18 |
SA07280403B1 (ar) | 2010-12-01 |
TN2009000024A1 (en) | 2010-08-19 |
EA200970172A1 (ru) | 2009-08-28 |
NZ574102A (en) | 2010-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA30636B1 (fr) | Promedicament d'un compose cinnamide | |
CY1124503T1 (el) | Βοριοφθαλιδια για θεραπευτικη χρηση | |
EA200801417A1 (ru) | Соединение бициклического циннамида | |
WO2008108380A3 (fr) | Composés de pyrrole | |
ME01992B (fr) | Composes diarylhydantoines | |
DK2123271T3 (da) | Lægemiddel til behandling af influenza | |
UY28290A1 (es) | Compuestos farmacéuticos novedosos | |
TW200605883A (en) | Condensed heterocycle derivative having HCV inhibitory activity | |
ATE503746T1 (de) | Neue imidazolidinderivate | |
EA200500862A1 (ru) | Синоменин и соединения синоменина, синтез и применение | |
TW200745034A (en) | New compounds | |
MA29399B1 (fr) | Nouveaux ligands du recepteur h3 de l'histamine et leurs applications therapeutiques | |
EA200300695A1 (ru) | Ингибитор высвобождения воспалительного цитокина | |
MX2010004232A (es) | Compuesto de indolina de pirimidilo. | |
ATE366249T1 (de) | Zyklische amid-derivate | |
WO2008136378A1 (fr) | Nouveau dérivé de sulfonamide et son sel | |
NO20042010L (no) | 4-imidazolin-2-on forbindelser | |
ATE525386T1 (de) | 3'-ethynylcytidinderivat | |
WO2004080389A3 (fr) | Composés de hydroxyeicosadiénamide | |
SE0402734D0 (sv) | Antimiicrobial compounds | |
TNSN07373A1 (fr) | 7-fluoro-1,3-dihydro-indole-2-one-oxazolidinones servant d'agents antibacteriens | |
CO5690574A2 (es) | Nuevos compuestos derivados de indolina como inhibidores de la colesterol-actiltransferasa (acat) y uso medico del mismo | |
ECSP055538A (es) | Cefalosporina | |
TNSN07374A1 (fr) | Oxindole-oxazolidinone servant d'agent antibacterien | |
TNSN08233A1 (en) | Bicyclic cinnamide compound |